//
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis
Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement
Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week